{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:58:53Z","timestamp":1791435533755,"version":"4.3.3"},"reference-count":67,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["BRC-1215-20014"],"award-info":[{"award-number":["BRC-1215-20014"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1053\/j.semnuclmed.2023.02.005","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T17:49:47Z","timestamp":1679593787000},"page":"530-538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Molecular Imaging of Pituitary Tumors"],"prefix":"10.1053","volume":"53","author":[{"given":"Daniel","family":"Gillett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6937-2775","authenticated-orcid":false,"given":"James","family":"MacFarlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2204-9169","authenticated-orcid":false,"given":"Waiel","family":"Bashari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosy","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3777-2827","authenticated-orcid":false,"given":"Iosif A.","family":"Mendichovszky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7452-4961","authenticated-orcid":false,"given":"Luigi","family":"Aloj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heok","family":"Cheow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gurnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0001","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11154-020-09556-7","article-title":"The epidemiology of aggressive pituitary tumors (and its challenges)","author":"Dekkers","year":"2020","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0002","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","article-title":"Clinical Biology of the Pituitary Adenoma","volume":"43","author":"Melmed","year":"2022","journal-title":"Endocr Rev"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0003","series-title":"Imaging in Endocrine Disorders","first-page":"97","article-title":"Magnetic resonance imaging of pituitary tumors","author":"Bonneville","year":"2016"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0004","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11102-017-0838-2","article-title":"Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): a pituitary society statement","volume":"20","author":"Casanueva","year":"2017","journal-title":"Pituitary."},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0005","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/RLU.0b013e3182485217","article-title":"A very rare case of nonfunctioning pituitary adenoma incidentally disclosed at 18F-FDG PET\/CT","volume":"37","author":"Maffei","year":"2012","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0006","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1210\/jc.2003-030525","article-title":"A Reappraisal of the Utility of Somatostatin Receptor Scintigraphy in Patients with Ectopic Adrenocorticotropin Cushing's Syndrome","volume":"88","author":"Tsagarakis","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0007","first-page":"728","article-title":"Indium-111 pentetreotide single-photon emission tomography in patients with TSH-secreting pituitary adenomas: Correlation with the effect of a single administration of octreotide on serum TSH levels","volume":"24","author":"Losa","year":"1997","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0008","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/BF03347337","article-title":"Scintigraphic imaging of pituitary adenomas: An in vivo evaluation of somatostatin receptors","author":"Oppizzi","year":"1998","journal-title":"J Endocrinol Invest"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0009","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1210\/jc.2003-031812","article-title":"The Role of [18F]Fluorodeoxyglucose Positron Emission Tomography and [111In]-Diethylenetriaminepentaacetate-d-Phe-Pentetreotide Scintigraphy in the Localization of Ectopic Adrenocorticotropin-Secreting Tumors Causing Cushing's Syndrome","volume":"89","author":"Pacak","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0010","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s12020-017-1486-z","article-title":"Use of 111In-pentetreotide scintigraphy for diagnosis and management of resistant macroprolactinoma","volume":"60","author":"Del Gatto","year":"2018","journal-title":"Endocrine"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0011","doi-asserted-by":"crossref","DOI":"10.1097\/00006231-199812000-00004","article-title":"Pituitary adenomas: The role of: 111: In-DTPA-octreotide SPET in the detection of minimal post-surgical residues","volume":"19","author":"Lauriero","year":"1998","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0012","first-page":"652","article-title":"Somatostatin Receptor Scintigraphy with Indium-111-DTPA-D-Phe-1-Octreotide in Man: Metabolism, Dosimetry and Comparison with Iodine-123-Tyr-3-Octreotide","volume":"33","author":"Krenning","year":"1992","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0013","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1259\/bjr\/51245688","article-title":"The role of somatostatin receptor scintigraphy in patients with pituitary adenoma or post-surgical recurrent tumours","volume":"78","author":"Acosta-Gomez","year":"2005","journal-title":"Br J Radiol"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0014","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.1097\/RLU.0000000000000328","article-title":"Pituitary Macroadenoma on 99mTc-TRODAT-1 Brain SPECT","volume":"39","author":"Hsieh","year":"2014","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s002590050358","article-title":"Comparison of iodine-123 epidepride and iodine-123 IBZM for dopamine D 2 receptor imaging in clinically non-functioning pituitary macroadenomas and macroprolactinomas","volume":"26","author":"De Herder","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0016","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF02336144","article-title":"Iodine-123-IBZM-SPECT: studies in 15 patients with pituitary tumors","volume":"97","author":"Pirker","year":"1994","journal-title":"J Neural Transm Sect JNT"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0017","first-page":"1184","article-title":"In Vivo Use of a Radioiodinated Somatostatin Analogue: Dynamics, Metabolism, and Binding to Somatostatin Receptor-Positive Tumors in Man","volume":"32","author":"Bakker","year":"1991","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0018","series-title":"Nuclear medicine physics: a handbook for teachers and students","year":"2014"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0019","series-title":"Endotext [Internet]","article-title":"Non-Functioning Pituitary Adenomas","author":"Drummond","year":"2000"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0020","series-title":"The Pituitary","first-page":"677","article-title":"Chapter 23 - Pituitary Imaging","author":"Bashari","year":"2022"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0021","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3904\/kjim.2013.28.1.81","article-title":"Analysis of 18F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions","volume":"28","author":"Seok","year":"2013","journal-title":"Korean J Intern Med"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0022","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/RLU.0000000000003710","article-title":"Gonadotropin-Secreting Pituitary Macroadenoma Complicated With Hemorrhagic Apoplexy in 18F-FDG PET\/CT","volume":"46","author":"Dejust","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0023","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/RLU.0000000000000457","article-title":"Comparison of 68Ga DOTATATE to 18F-FDG uptake is useful in the differentiation of residual or recurrent pituitary adenoma from the remaining pituitary tissue after transsphenoidal adenomectomy","volume":"39","author":"Zhao","year":"2014","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0024","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1186\/s12885-021-08574-1","article-title":"The combination of 13N-ammonia and 11C-methionine in differentiation of residual\/recurrent pituitary adenoma from the pituitary gland remnant after trans-sphenoidal Adenomectomy","author":"Zhang","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0025","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.RLU.0000057554.55930.05","article-title":"Pituitary adenoma detected on FDG positron emission tomography in a patient with mucosa-associated lymphoid tissue lymphoma","volume":"28","author":"Campeau","year":"2003","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0026","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1552-6569.2008.00347.x","article-title":"Pituitary adenomas can appear as hypermetabolic lesions in 18F-FDG PET imaging","volume":"20","author":"Ryu","year":"2010","journal-title":"J Neuroimaging"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0027","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/0972-3919.84611","article-title":"Incidental detection of clinically occult follicle stimulating hormone secreting pituitary adenoma on whole body 18-Fluorodeoxyglucose positron emission tomography-computed tomography","volume":"26","author":"Joshi","year":"2011","journal-title":"Indian J Nucl Med IJNM Off J Soc Nucl Med India"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0028","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1007\/s00259-010-1571-5","article-title":"Incidental pituitary uptake on whole-body 18 F-FDG PET\/CT: a multicentre study","volume":"37","author":"Jeong","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0029","article-title":"Pituitary adenoma & nuclear medicine: Recent outcomes and ongoing developments","volume":"51","author":"Chevalier","year":"2022","journal-title":"Presse Medicale Paris Fr"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11102-019-01025-y","article-title":"Diagnosis and management of prolactinomas: current challenges","volume":"23","author":"Petersenn","year":"2020","journal-title":"Pituitary"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0031","doi-asserted-by":"crossref","first-page":"dgz076","DOI":"10.1210\/clinem\/dgz076","article-title":"Impulse Control Disorders in Dopamine Agonist-Treated Hyperprolactinemia: Prevalence and Risk Factors","volume":"105","author":"De Sousa","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0032","first-page":"1089","article-title":"Impulse control disorders in hyperprolactinemic patients on dopamine agonist therapy","volume":"23","author":"Hamidianjahromi","year":"2022","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0033","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1210\/clinem\/dgz144","article-title":"Surgery as a Viable Alternative First-Line Treatment for Prolactinoma Patients. A Systematic Review and Meta-Analysis","volume":"105","author":"Zamanipoor Najafabadi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0034","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11102-022-01229-9","article-title":"11C-methionine PET aids localization of microprolactinomas in patients with intolerance or resistance to dopamine agonist therapy","volume":"25","author":"Bashari","year":"2022","journal-title":"Pituitary"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0035","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4103\/wjnm.WJNM_83_20","article-title":"18F-fallypride and 11C-methionine positron emission tomography\/computed tomography for the study of prolactinomas and nonfunctioning pituitary adenomas: A case series","volume":"20","author":"Damian","year":"2021","journal-title":"World J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0036","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-023-03310-0","article-title":"DRD2 expression based on 18F-fallypride PET\/MR predicts the dopamine agonist resistance of prolactinomas: a pilot study","author":"Tang","year":"2023","journal-title":"Endocrine"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0037","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1097\/RLU.0000000000001721","article-title":"18F-FDOPA PET Imaging in Prolactinoma","volume":"42","author":"Ginet","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0038","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1097\/RLU.0000000000002202","article-title":"18F-FDOPA Uptake Reflects the Efficacy of Dopamine Agonists Treatment in Pituitary Prolactinoma","volume":"43","author":"Heimburger","year":"2018","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0039","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s11102-022-01258-4","article-title":"Cardiovascular health and mortality in Cushing's disease","volume":"25","author":"Coulden","year":"2022","journal-title":"Pituitary"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0040","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0041","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s11102-022-01236-w","article-title":"Modern imaging in Cushing's disease","volume":"25","author":"Bashari","year":"2022","journal-title":"Pituitary"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2021.101513","article-title":"New types of localization methods for adrenocorticotropic hormone-dependent Cushing's syndrome","volume":"35","author":"Senanayake","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0043","doi-asserted-by":"crossref","first-page":"M107","DOI":"10.1530\/EJE-15-0616","article-title":"A role for 11C-methionine PET imaging in ACTH-dependent Cushing's syndrome","volume":"173","author":"Koulouri","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0044","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00003072-200203000-00005","article-title":"Serendipitous detection of Cushing's disease by FDG positron emission tomography and a review of the literature","volume":"27","author":"Komori","year":"2002","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0045","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11102-009-0180-4","article-title":"The diagnostic value of fused positron emission tomography\/computed tomography in the localization of adrenocorticotropin-secreting pituitary adenoma in Cushing's disease","volume":"12","author":"Alzahrani","year":"2009","journal-title":"Pituitary"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0046","first-page":"523","article-title":"PET\/MRI in the Diagnosis of Hormone-Producing Pituitary Microadenoma: A Prospective Pilot Study","volume":"59","author":"Wang","year":"2018","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0047","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","article-title":"Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer","volume":"47","author":"Chen","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0048","first-page":"1","article-title":"CRH stimulation improves 18 F-FDG-PET detection of pituitary adenomas in Cushing's disease","author":"Boyle","year":"2019","journal-title":"Endocrine"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0049","first-page":"642","article-title":"Development of 68Ga DOTA-CRH for PET\/CT Imaging of ACTH-Dependent Cushing's Disease: Initial Study","volume":"36","author":"Shukla","year":"2021","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0050","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1210\/clinem\/dgaa755","article-title":"Molecular Imaging Targeting Corticotropin-releasing Hormone Receptor for Corticotropinoma: A Changing Paradigm","volume":"106","author":"Walia","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0051","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/RLU.0000000000004244","article-title":"Usefulness of 68 Ga-Pentixafor PET\/CT on Diagnosis and Management of Cushing Syndrome","volume":"47","author":"Ding","year":"2022","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0052","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41572-019-0071-6","article-title":"Acromegaly","volume":"5","author":"Colao","year":"2019","journal-title":"Nat Rev Dis Primer"},{"issue":"3\u20134","key":"10.1053\/j.semnuclmed.2023.02.005_bib0053","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000095529","article-title":"Positron emission tomography in acromegaly and other pituitary adenoma patients","volume":"83","author":"Muhr","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0054","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1530\/EJE-16-0639","article-title":"Successful treatment of residual pituitary adenoma in persistent acromegaly following localisation by 11C-methionine PET co-registered with MRI","volume":"175","author":"Koulouri","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0055","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.3171\/2020.3.FOCUS2052","article-title":"PET-guided repeat transsphenoidal surgery for previously deemed unresectable lateral disease in acromegaly","volume":"48","author":"Bashari","year":"2020","journal-title":"Neurosurg Focus"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0056","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.wneu.2013.11.011","article-title":"Clinical usefulness of coregistered 11C-methionine positron emission tomography\/3-T magnetic resonance imaging at the follow-up of acromegaly","volume":"82","author":"Rodriguez-Barcelo","year":"2014","journal-title":"World Neurosurg"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0057","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00259-021-05458-1","article-title":"Positive [18F]fluoroethyltyrosine PET\/MRI in suspected recurrence of growth hormone-producing pituitary adenoma in a paediatric patient","volume":"49","author":"Veldhuijzen van Zanten","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0058","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S2213-8587(16)30311-4","article-title":"Localisation of an occult thyrotropinoma with 11 C-methionine PET-CT before and after somatostatin analogue therapy","volume":"4","author":"Koulouri","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0059","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13550-022-00899-7","article-title":"Localization of TSH-secreting pituitary adenoma using 11C-methionine image subtraction","volume":"12","author":"Gillett","year":"2022","journal-title":"EJNMMI Res"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0060","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/cen.14425","article-title":"Pre- and postoperative 68 Ga-DOTATOC positron emission tomography for hormone-secreting pituitary neuroendocrine tumours","volume":"94","author":"Tj\u00f6rnstrand","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"supplement 1","key":"10.1053\/j.semnuclmed.2023.02.005_bib0061","article-title":"First performance measurements of a new multi-detector CZT-Based SPECT\/CT system: GE StarGuide","volume":"62","author":"Rouzic","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0062","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1053\/j.semnuclmed.2022.01.004","article-title":"Recent Developments in SPECT\/CT","volume":"52","author":"Ritt","year":"2022","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0063","doi-asserted-by":"crossref","first-page":"520","DOI":"10.2967\/jnumed.108.054726","article-title":"Tissue Classification as a Potential Approach for Attenuation Correction in Whole-Body PET\/MRI: Evaluation with PET\/CT Data","volume":"50","author":"Martinez-M\u00f6ller","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0064","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s41205-021-00118-4","article-title":"Methods of 3D printing models of pituitary tumors","volume":"7","author":"Gillett","year":"2021","journal-title":"3D Print Med"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/mrm.25545","article-title":"Zero TE MR bone imaging in the head","volume":"75","author":"Wiesinger","year":"2016","journal-title":"Magn Reson Med"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0066","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1109\/TRPMS.2018.2886838","article-title":"Clinical Evaluation of 11C-Met-Avid Pituitary Lesions Using a ZTE-Based AC Method","volume":"3","author":"Delso","year":"2019","journal-title":"IEEE Trans Radiat Plasma Med Sci"},{"key":"10.1053\/j.semnuclmed.2023.02.005_bib0067","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s11102-021-01160-5","article-title":"Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET\/MRI","volume":"24","author":"Berkmann","year":"2021","journal-title":"Pituitary"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299823000119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299823000119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:41:28Z","timestamp":1757544088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299823000119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0001299823000119"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2023.02.005","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Imaging of Pituitary Tumors","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2023.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}